ConductScience.org, home

Paper780312

Effects of the intracoronary and intraventricular injections of a commonly available vs. a newly available contrast medium.

Baltaxe HA and 2 others. Invest Radiol, 1976. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Effects of the intracoronary and intraventricular injections of a commonly available vs. a newly available contrast medium. Papers, record 780312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/780312

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of the intracoronary and intraventricular injections of a commonly available vs. a newly available contrast medium.
PubMed
Journal
Invest Radiol
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.48
iCite
Revised in PubMed
2019-08-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baltaxe HAH A
2Sos TAT A
3McGrath MBM B

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AngiocardiographyMajor topic
Contrast MediaMajor topic
DiatrizoateMajor topic
IodobenzoatesMajor topic
Metrizoic AcidMajor topic
Aspartate Aminotransferases
Blood Pressure
Cardiac Output
Clinical Trials as Topic
Coronary Disease
Coronary Vessels
Creatine Kinase
Evaluation Studies as Topic
Heart Rate
Heart Ventricles
Humans
Injections
Injections, Intra-Arterial
L-Lactate Dehydrogenase

Source PubMed

Download CSV of topics

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
7206593[Reduced cardiotoxicity of contrast media in angiocardiography. Comparative clinical study using diatrizoate with added calcium or metrizamide (author's transl)].Klin Wochenschr1980https://conductscience.org/library/papers/7206593PubMed
7151098Experimental myocardial ischemia II: radiographic contrast media toxicity.Cardiovasc Intervent Radiol1982https://conductscience.org/library/papers/7151098PubMed
6383445Contrast agents in angiocardiography.Br Heart J1984https://conductscience.org/library/papers/6383445PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/780312

GET https://conductscience.org/api/papers/v1/780312/authors